XML 30 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value of Assets and Liabilities
3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Disclosures
Fair Value of Assets and Liabilities
Fair Value Measurement
General accounting principles for Fair Value Measurements and Disclosures define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. These principles also establish a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value and describes three levels of inputs that may be used to measure fair value:
Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities. The Company’s Level 1 assets and liabilities are traded in active exchange markets.
Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or market standard valuation techniques and assumptions that use significant inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the related assets or liabilities. Prices are determined using valuation methodologies such as discounted cash flow models and other similar techniques that require management’s judgment or estimation in developing inputs that are consistent with what other market participants would use when pricing similar assets and liabilities. Additionally, the Company’s embedded derivatives, all of which are associated with reinsurance treaties and longevity and mortality swaps, are classified in Level 3 since their values include significant unobservable inputs.
For a discussion of the Company’s valuation methodologies for assets and liabilities measured at fair value and the fair value hierarchy, see Note 6 in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report.

Assets and Liabilities by Hierarchy Level
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2019 and December 31, 2018 are summarized below (dollars in thousands):
March 31, 2019:
 
 
 
Fair Value Measurements Using:
 
 
Total    
 
Level 1        
 
Level 2    
 
Level 3    
Assets:
 
 
 
 
 
 
 
 
Fixed maturity securities – available-for-sale:
 
 
 
 
 
 
 
 
Corporate
 
$
25,077,338

 
$

 
$
23,546,583

 
$
1,530,755

Canadian government
 
4,277,864

 

 
3,670,073

 
607,791

RMBS
 
1,994,186

 

 
1,987,664

 
6,522

ABS
 
2,241,986

 

 
2,128,199

 
113,787

CMBS
 
1,431,746

 

 
1,431,725

 
21

U.S. government
 
1,567,563

 
1,464,139

 
86,215

 
17,209

State and political subdivisions
 
792,717

 

 
782,555

 
10,162

Other foreign government
 
4,355,043

 

 
4,349,977

 
5,066

Total fixed maturity securities – available-for-sale
 
41,738,443

 
1,464,139

 
37,982,991

 
2,291,313

Equity securities
 
89,865

 
49,443

 

 
40,422

Funds withheld at interest – embedded derivatives
 
107,506

 

 

 
107,506

Cash equivalents
 
855,265

 
853,927

 
1,319

 
19

Short-term investments
 
75,360

 
4,766

 
41,392

 
29,202

Other invested assets:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
48,683

 

 
48,683

 

Foreign currency forwards
 
33,113

 

 
33,113

 

Credit default swaps
 
(6,201
)
 

 
(6,201
)
 

Equity options
 
18,676

 

 
18,676

 

Foreign currency swaps
 
38,141

 

 
38,141

 

FVO contractholder-directed unit-linked investments
 
202,848

 
201,833

 
1,015

 

Total other invested assets
 
335,260

 
201,833

 
133,427

 

Other assets - longevity swaps
 
48,869

 

 

 
48,869

Total
 
$
43,250,568

 
$
2,574,108

 
$
38,159,129

 
$
2,517,331

Liabilities:
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities – embedded derivatives
 
$
903,935

 
$

 
$

 
$
903,935

Other liabilities:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
17,620

 

 
17,620

 

Foreign currency swaps - non-hedged
 
4,629

 

 
4,629

 

CPI swaps
 
20,505

 

 
20,505

 

Credit default swaps
 
(12,757
)
 

 
(12,757
)
 

Equity options
 
(1,476
)
 

 
(1,476
)
 

Mortality swaps
 
(489
)
 

 

 
(489
)
Total
 
$
931,967

 
$

 
$
28,521

 
$
903,446

December 31, 2018:
 
 
 
Fair Value Measurements Using:
 
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
 
Fixed maturity securities – available-for-sale:
 
 
 
 
 
 
 
 
Corporate
 
$
23,982,119

 
$

 
$
22,651,194

 
$
1,330,925

Canadian government
 
3,892,385

 

 
3,364,261

 
528,124

RMBS
 
1,869,221

 

 
1,862,366

 
6,855

ABS
 
2,149,204

 

 
2,053,632

 
95,572

CMBS
 
1,419,034

 

 
1,419,012

 
22

U.S. government
 
2,185,874

 
2,067,529

 
100,320

 
18,025

State and political subdivisions
 
752,194

 

 
741,992

 
10,202

Other foreign government
 
3,742,315

 

 
3,737,309

 
5,006

Total fixed maturity securities – available-for-sale
 
39,992,346

 
2,067,529

 
35,930,086

 
1,994,731

Equity securities
 
82,197

 
48,737

 

 
33,460

Funds withheld at interest – embedded derivatives
 
109,597

 

 

 
109,597

Cash equivalents
 
485,167

 
473,509

 
11,658

 

Short-term investments
 
105,991

 
4,989

 
98,774

 
2,228

Other invested assets:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
37,976

 

 
37,976

 

Foreign currency forwards
 
50,740

 

 
50,740

 

Credit default swaps
 
4,466

 

 
4,466

 

Equity options
 
36,206

 

 
36,206

 

Foreign currency swaps
 
51,311

 

 
51,311

 

FVO contractholder-directed unit-linked investments
 
197,770

 
196,781

 
989

 

Total other invested assets
 
378,469

 
196,781

 
181,688

 

Other assets - longevity swaps
 
47,789

 

 

 
47,789

Total
 
$
41,201,556

 
$
2,791,545

 
$
36,222,206

 
$
2,187,805

Liabilities:
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities – embedded derivatives
 
$
944,865

 
$

 
$

 
$
944,865

Other liabilities:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
18,542

 

 
18,542

 

Foreign currency swaps - non-hedged
 
4,155

 

 
4,155

 

CPI swaps
 
11,384

 

 
11,384

 

Credit default swaps
 
(371
)
 

 
(371
)
 

Equity options
 
(6,630
)
 

 
(6,630
)
 

Mortality swaps
 
369

 

 

 
369

Total
 
$
972,314

 
$

 
$
27,080

 
$
945,234


Transfers between Levels 1 and 2
Transfers between Levels 1 and 2 are made to reflect changes in observability of inputs and market activity. The Company recognizes transfers of assets and liabilities into and out of levels within the fair value hierarchy at the beginning of the quarter in which the actual event or change in circumstances that caused the transfer occurs. There were no transfers between Level 1 and Level 2 during the three months ended March 31, 2019 or 2018.
Quantitative Information Regarding Internally - Priced Assets and Liabilities
The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements that are developed internally by the Company as of March 31, 2019 and December 31, 2018 (dollars in thousands):
 
 
Estimated Fair Value      
 
Valuation Technique
 
Unobservable Inputs
 
Range (Weighted Average) 
March 31, 2019
 
December 31, 2018
 
 
 
March 31, 2019
 
December 31, 2018
Assets:
 
 
 
 
 
 
 
 
 
 
 
Corporate
$740,698
 
$642,647
 
Market comparable securities
 
Liquidity premium
 
0-5% (1%)

 
0-5%  (1%)

 
 
 
 
 
 
 
EBITDA Multiple
 
5.9x

 
5.9x-7.5x (6.5x)

ABS
81,417

 
77,842

 
Market comparable securities
 
Liquidity premium
 
0-1% (1%)

 
0-1%  (1%)

U.S. government
17,209

 
18,025

 
Market comparable securities
 
Liquidity premium
 
0-1% (1%)

 
0-1%  (1%)

Other foreign government
5,066

 
5,006

 
Market comparable
securities
 
Liquidity premium
 
1
%
 
1
%
Equity securities
30,294

 
25,007

 
Market comparable securities
 
Liquidity premium
 
4
%
 
4
%
 
 
 
 
 
 
 
EBITDA Multiple
 
6.9x-12.3x (8.2x)

 
6.9x-12.3x (7.9x)

Funds withheld at interest- embedded derivatives
107,506

 
109,597

 
Total return swap
 
Mortality
 
0-100%  (2%)

 
0-100%  (2%)

 
 
 
 
 
 
 
Lapse
 
0-35%  (11%)

 
0-35%  (10%)

 
 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
0-5%  (3%)

 
 
 
 
 
 
 
CVA
 
0-5%  (1%)

 
0-5%  (1%)

 
 
 
 
 
 
 
Crediting rate
 
2-4%  (2%)

 
2-4%  (2%)

Longevity swaps
48,869

 
47,789

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
0-100%  (2%)

 
 
 
 
 
 
 
Mortality improvement
 
(10%)-10%   (3%)

 
(10%)-10%  (3%)

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities- embedded derivatives- indexed annuities
754,171

 
776,940

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
0-100% (2%)

 
 
 
 
 
 
 
Lapse
 
0-35%  (11%)

 
0-35% (10%)

 
 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
0-5% (3%)

 
 
 
 
 
 
 
Option budget projection
 
2-4%  (2%)

 
2-4% (2%)

Interest sensitive contract liabilities- embedded derivatives- variable annuities
149,764

 
167,925

 
Discounted cash 
flow
 
Mortality
 
0-100% (1%)

 
0-100% (1%)

 
 
 
 
 
 
 
Lapse
 
0-25% (5%)

 
0-25% (5%)

 
 
 
 
 
 
 
Withdrawal
 
0-7% (4%)

 
0-7% (5%)

 
 
 
 
 
 
 
CVA
 
0-5% (1%)

 
0-5% (1%)

 
 
 
 
 
 
 
Long-term volatility
 
0-27% (13%)

 
0-27% (13%)

Mortality swaps
(489
)
 
369

 
Discounted cash flow
 
Mortality
 
0-100%  (1%)

 
0-100%  (1%)



Changes in Level 3 Assets and Liabilities
Assets and liabilities transferred into Level 3 are due to a lack of observable market transactions and price information. Transfers out of Level 3 are primarily the result of the Company obtaining observable pricing information or a third party pricing quotation that appropriately reflects the fair value of those assets and liabilities. In 2018, the Company transferred equity securities with a fair value of approximately $38.9 million into Level 3 as a result of the adoption of the new accounting guidance for the recognition and measurement of equity securities (see “New Accounting Pronouncements – Financial Instruments – Recognition and Measurement” in Note 2 – “Significant Accounting Policies and Pronouncements” in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report).
For further information on the Company’s valuation processes, see Note 6 in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report.
The reconciliations for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) are as follows (dollars in thousands):
For the three months ended March 31, 2019:
 
Fixed maturity securities - available-for-sale
 
 
Corporate
 
Canadian government
 
RMBS
 
ABS
Fair value, beginning of period
 
$
1,330,925

 
$
528,124

 
$
6,855

 
$
95,572

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
133

 
3,493

 
2

 
17

Included in other comprehensive income
 
19,404

 
76,174

 
1

 
975

Purchases(1)
 
214,441

 

 

 
31,322

Sales(1)
 
(10,712
)
 

 

 

Settlements(1)
 
(23,436
)
 

 
(336
)
 
(14,099
)
Fair value, end of period
 
$
1,530,755

 
$
607,791

 
$
6,522

 
$
113,787

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$
166

 
$
3,493

 
$
2

 
$
17

For the three months ended March 31, 2019 (continued):
 
Fixed maturity securities - available-for-sale
 
 
 
 
CMBS
 
U.S. government
 
State
and political
subdivisions
 
Other foreign government
 
Equity securities
Fair value, beginning of period
 
$
22

 
$
18,025

 
$
10,202

 
$
5,006

 
33,460

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 

 
(89
)
 
5

 

 

Investment related gains (losses), net
 

 

 

 

 
3,762

Included in other comprehensive income
 

 
267

 
(7
)
 
60

 

Purchases(1)
 

 
84

 

 

 
3,200

Settlements(1)
 
(1
)
 
(1,078
)
 
(38
)
 

 

Fair value, end of period
 
$
21

 
$
17,209

 
$
10,162

 
$
5,066

 
$
40,422

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$

 
$
(89
)
 
$
5

 
$

 
$

Investment related gains (losses), net
 

 

 

 

 
3,762


 
For the three months ended March 31, 2019 (continued):
 
Funds withheld
at interest-
embedded
derivatives
 
Cash equivalents
 
Short-term investments
 
Other assets - longevity swaps
 
Interest sensitive contract liabilities embedded derivatives
 
Other liabilities - mortality swaps
Fair value, beginning of period
 
$
109,597

 
$

 
$
2,228

 
$
47,789

 
$
(944,865
)
 
$
(369
)
Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 

 

 
32

 

 

 

Investment related gains (losses), net
 
(2,091
)
 

 

 

 
18,161

 

Interest credited
 

 

 

 

 
3,070

 

Included in other comprehensive income
 

 

 
199

 
(1,063
)
 

 

Other revenues
 

 

 

 
2,143

 

 
858

Purchases(1)
 

 
19

 
26,743

 

 
1,398

 

Settlements(1)
 

 

 

 

 
18,301

 

Fair value, end of period

$
107,506

 
$
19

 
$
29,202

 
$
48,869

 
$
(903,935
)
 
$
489

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$

 
$

 
$
32

 
$

 
$

 
$

Investment related gains (losses), net
 
(2,091
)
 

 

 

 
16,766

 

Other revenues
 

 

 

 
2,143

 

 
858

Interest credited
 

 

 

 

 
(15,231
)
 


For the three months ended March 31, 2018:
 
Fixed maturity securities - available-for-sale
 
 
Corporate
 
Canadian government
 
RMBS
 
ABS
Fair value, beginning of period
 
$
1,337,272

 
$
593,942

 
$
107,882

 
$
123,474

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
(361
)
 
3,444

 
(92
)
 
106

Investment related gains (losses), net
 

 

 

 
2

Included in other comprehensive income
 
(32,852
)
 
(24,639
)
 
(1,110
)
 
853

Purchases(1)
 
100,170

 

 
20,916

 
11,000

Sales(1)
 
(6,180
)
 

 

 

Settlements(1)
 
(75,146
)
 

 
(2,963
)
 
(2,739
)
Transfers into Level 3
 
7,166

 

 

 

Transfers out of Level 3
 
(30,805
)
 

 
(4,019
)
 
(1,990
)
Fair value, end of period
 
$
1,299,264

 
$
572,747

 
$
120,614

 
$
130,706

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$
(361
)
 
$
3,444

 
$
(92
)
 
$
106

For the three months ended March 31, 2018 (continued):
 
Fixed maturity securities - available-for-sale
 
 
CMBS
 
U.S. government
 
State
and political
subdivisions
 
Other foreign government
Fair value, beginning of period
 
$
3,234

 
$
22,511

 
$
41,203

 
$
5,092

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 

 
(110
)
 
8

 

Included in other comprehensive income
 
(47
)
 
(340
)
 
700

 
(88
)
Purchases(1)
 

 
96

 

 

Settlements(1)
 
(1
)
 
(1,104
)
 
(35
)
 

Transfers out of Level 3
 
(1,302
)
 

 

 

Fair value, end of period
 
$
1,884

 
$
21,053

 
$
41,876

 
$
5,004

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$

 
$
(110
)
 
$
8

 
$


 
For the three months ended March 31, 2018 (continued):
 
Equity securities
 
Funds withheld
at interest-
embedded
derivatives
 
Short-term investments
 
Other assets - longevity swaps
 
Interest sensitive contract liabilities embedded derivatives
 
Other liabilities - mortality swaps
Fair value, beginning of period
 
$

 
$
122,194

 
$
3,096

 
$
40,659

 
$
(1,014,229
)
 
$
(1,683
)
Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment related gains (losses), net
 
(2,677
)
 
13,611

 

 

 
14,785

 

Interest credited
 

 

 

 

 
25,351

 

Included in other comprehensive income
 

 

 
(25
)
 
1,085

 

 

Other revenues
 

 

 

 
2,267

 

 

Purchases(1)
 

 

 
146

 

 
(8,508
)
 

Sales(1)
 
(28
)
 

 

 

 

 

Settlements(1)
 
(48
)
 

 

 

 
17,807

 

Transfers into Level 3
 
38,905

 

 

 

 

 

Fair value, end of period
 
$
36,152

 
$
135,805

 
$
3,217

 
$
44,011

 
$
(964,794
)
 
$
(1,683
)
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment related gains (losses), net
 
$
(2,705
)
 
$
13,611

 
$

 
$

 
$
12,901

 
$

Other revenues
 

 

 

 
2,267

 

 

Interest credited
 

 

 

 

 
7,544

 


(1)
The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
Nonrecurring Fair Value Measurements
During the three months ended March 31, 2019 and March 31, 2018, the Company did not have any adjustments to its financial instruments measured at fair value on a nonrecurring basis that are still held at the reporting date.
Fair Value of Financial Instruments
The Company is required by general accounting principles for Fair Value Measurements and Disclosures to disclose the fair value of certain financial instruments including those that are not carried at fair value. The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments, which were not measured at fair value on a recurring basis, as of March 31, 2019 and December 31, 2018 (dollars in thousands). For additional information regarding the methods and significant assumptions used by the Company to estimate these fair values, see Note 6 in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report. This table excludes any payables or receivables for collateral under repurchase agreements and other transactions. The estimated fair value of the excluded amount approximates carrying value as they equal the amount of cash collateral received/paid.
March 31, 2019:
 
Carrying Value (1)
 
Estimated 
Fair Value
 
Fair Value Measurement Using:
Level 1
 
Level 2
 
Level 3
 
NAV
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage loans on real estate
 
$
5,117,545

 
$
5,210,513

 
$

 
$

 
$
5,210,513

 
$

Policy loans
 
1,312,349

 
1,312,349

 

 
1,312,349

 

 

Funds withheld at interest
 
5,619,039

 
5,823,245

 

 

 
5,823,245

 

Cash and cash equivalents
 
1,165,131

 
1,165,131

 
1,165,131

 

 

 

Short-term investments
 
43,855

 
43,855

 
43,855

 

 

 

Other invested assets
 
1,061,220

 
1,060,931

 
5,176

 
83,529

 
603,835

 
368,391

Accrued investment income
 
442,956

 
442,956

 

 
442,956

 

 

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Interest-sensitive contract liabilities
 
$
14,543,332

 
$
14,790,369

 
$

 
$

 
$
14,790,369

 
$

Long-term debt
 
2,787,717

 
2,915,623

 

 

 
2,915,623

 

Collateral finance and securitization notes
 
656,174

 
601,680

 

 

 
601,680

 

 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2018:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage loans on real estate
 
$
4,966,298

 
$
4,917,416

 
$

 
$

 
$
4,917,416

 
$

Policy loans
 
1,344,980

 
1,344,980

 

 
1,344,980

 

 

Funds withheld at interest
 
5,655,055

 
5,802,518

 

 

 
5,802,518

 

Cash and cash equivalents
 
1,404,566

 
1,404,566

 
1,404,566

 

 

 

Short-term investments
 
36,607

 
36,607

 
36,607

 

 

 

Other invested assets
 
945,731

 
941,449

 
4,640

 
83,203

 
477,214

 
376,392

Accrued investment income
 
427,893

 
427,893

 

 
427,893

 

 

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Interest-sensitive contract liabilities
 
$
14,547,436

 
$
14,611,011

 
$

 
$

 
$
14,611,011

 
$

Long-term debt
 
2,787,873

 
2,752,047

 

 

 
2,752,047

 

Collateral finance and securitization notes
 
681,961

 
626,731

 

 

 
626,731

 

 
(1)
Carrying values presented herein may differ from those in the Company’s condensed consolidated balance sheets because certain items within the respective financial statement captions may be measured at fair value on a recurring basis.